- জেনেরিক নাম
- Trimetazidine Dihydrochloride
- শক্তি
- 20 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Incepta Pharmaceuticals Ltd.
৳ ২.৯৪ ৳ ৩ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
বাংলাদেশে Feelnor 20 mg Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Trimetazidine Dihydrochloride আছে (২০ mg)। দাম: প্রতি ইউনিট ৩ টাকা। এই ব্র্যান্ডের প্রস্তুতকারক Incepta Pharmaceuticals Ltd। Trimetazidine Dihydrochloride-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Trimetazidine Dihydrochloride-এর ১৩টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। ইউনিট দামের হিসেবে Feelnor এগুলোর মধ্যে সবচেয়ে কম দামিদের একটি।
Feelnor is a tablet from Incepta Pharmaceuticals Ltd., with the generic name Trimetazidine Dihydrochloride. It is prescribed in adults as add-on therapy for stable angina pectoris when first-line anti-anginal medicines do not control symptoms adequately or are not tolerated. It contains Trimetazidine Dihydrochloride and is used in adults as add-on therapy for the symptomatic treatment of stable angina pectoris when first-line antianginal therapies do not control symptoms well or are not tolerated. Whether it suits you is a decision for your doctor.
Feelnor is not a curative treatment for angina attacks and is not an initial treatment for unstable angina or a treatment for myocardial infarction. Feelnor is used in adults alongside other medicines for the symptomatic treatment of stable angina pectoris, when first-line anti-anginal therapies are not adequate or are not tolerated. Your doctor will decide if it is suitable for you.
Swallow the tablet as your doctor or pharmacist instructs. Swallow the tablet with water. Feelnor is taken by mouth. Tell your doctor about other medicines you take and any health conditions before starting. Do not change the dose or stop the medicine on your own.
Get medical help promptly if you have a serious reaction, or if you notice tremors, unusual movements or worsening symptoms, as the doctor may need to review the treatment. Tell the doctor or pharmacist if any of these bother you or do not go away. Seek medical advice promptly if you develop a serious or unexpected reaction. Do not stop or change the medicine without medical advice. Contact your doctor if you notice anything unusual after taking it.
Feelnor is not a curative treatment for angina attacks, not an initial treatment for unstable angina and not a treatment for myocardial infarction. Feelnor is not suitable for everyone. It is unknown whether it passes into human milk, so it should not be used during breastfeeding. Tell your doctor if you are pregnant, planning pregnancy or breast-feeding, and ask a doctor first if you have kidney problems or movement symptoms.
Feelnor is not a curative treatment for angina attacks and is not an initial treatment for unstable angina or a treatment for myocardial infarction. Feelnor is used in adults alongside other medicines for the symptomatic treatment of stable angina pectoris, when first-line anti-anginal therapies are not adequate or are not tolerated.
Swallow the tablet as your doctor or pharmacist instructs. Swallow the tablet with water.
Get medical help promptly if you have a serious reaction, or if you notice tremors, unusual movements or worsening symptoms, as the doctor may need to review the treatment. Tell the doctor or pharmacist if any of these bother you or do not go away.
Feelnor is not a curative treatment for angina attacks, not an initial treatment for unstable angina and not a treatment for myocardial infarction. Feelnor is not suitable for everyone.
৳ ২.৯৪ ৳ ৩ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Trimetazidine Dihydrochloride is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Trimetazidine Dihydrochloride is the first 3- keto acyl CoA thiolase inhibitor (KAT), a metabolic anti-ischemic agent with proven benefits for all coronary patients. Trimetazidine Dihydrochloride inhibits fatty acid pathway by inhibiting 3-keto acyl CoA thiolase enzyme and transfers oxygen to glucose pathway. Since glucose pathway is more efficient in producing energy, the same oxygen produces more energy and makes the heart more active. Moreover, the aerobic oxidation of glucose stops production of lactic acid, which prevents angina pectoris.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The recommended dose of Trimetazidine is 35 mg twice daily or 20 mg tablet thrice daily during meals. The benefit of the treatment should be assessed after three months and Trimetazidine should be discontinued if there is no treatment response.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
No drug interaction so far has been reported. In particular, no interaction has been reported with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents or digitalis preparation.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Trimetazidine is contraindicated in patients who have hypersensitivity to the active substance or to any of the excipients. It is also is contraindicated in patients with Parkinson’s disease, parkinsonian symptoms, tremors, restless legs movement disorders, severe renal impairment.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Trimetazidine is safe and well tolerated. The Common side effects associated with Trimetazidine are dizziness, headache, abdominal pain, diarrhoea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria and astheniaএই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There is no data on the use of Trimetazidine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of Trimetazidine during pregnancy. It is unknown whether Trimetazidine is excreted in human milk. A risk to the newborns/infants cannot be excluded. Trimetazidine should not be used during breast-feeding.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Trimetazidine is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris. It is also not a treatment for myocardial infarction.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Keep in a dry place away from light and heat. Keep out of the reach of children.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।